Condition (MeSH)
Platelet Storage Pool Deficiency
ClinicalTrials.gov lists 13 trials for Platelet Storage Pool Deficiency or a narrower condition beneath it. National Human Genome Research Institute (NHGRI) has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 13 trials are tagged with Platelet Storage Pool Deficiency itself; the rest are tagged with a narrower condition beneath it.
When did Platelet Storage Pool Deficiency trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2015 | 1 |
| 2011 | 1 |
| 2007 | 2 |
| 2005 | 1 |
| 2004 | 2 |
| 2002 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 13 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Platelet Storage Pool Deficiency trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 3 |
| Observational | 9 |
How many Platelet Storage Pool Deficiency trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Completed | 5 |
| Terminated | 1 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Platelet Storage Pool Deficiency trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Human Genome Research Institute (NHGRI) | 6 |
| 23andMe, Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| William Gahl, M.D. | 1 |
Which drugs are being tested for Platelet Storage Pool Deficiency? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| INFLIXIMAB | 1 |
| MERCAPTOPURINE | 1 |
| Zileuton | 1 |
Interventions as named in the registry (10)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Pirfenidoneone | 2 |
| Adalimumab-US | 1 |
| Pravastatin Pill | 1 |
| Low dose losartan | 1 |
| N Acetylcysteine | 1 |
Showing 5 of 10 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Platelet Storage Pool Deficiency trials report? (5)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Respiratory failure | 5 | 2 |
| Blood creatinine phosphokinase increased | 2 | 1 |
| Chest pain | 2 | 1 |
| Deep vein thrombosis | 1 | 1 |
| Haematochezia | 1 | 1 |
Which publications cover Platelet Storage Pool Deficiency? (1)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Clinical and Laboratory Findings in Patients with δ-Storage Pool Disease: A Case Series. | Seminars in thrombosis and hemostasis | 2017 | Yes |
Prevalence (1)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Alpha delta granule deficiency | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: rare-disease identity.